Who invested in Expedition Therapeutics?
One investor is on record as having backed Expedition Therapeutics — Developing next-generation DPP1 inhibitor for COPD, in Biotech. Each row below says whether the round came from the investor's own portfolio page or from the press.
Expedition Therapeutics investors
The funds that backed Expedition Therapeutics are in the directory.
If they wrote this cheque, they may write yours. Pitch2Fund scores your startup against every one of them, gives you the partner to write to, and drafts the email. Free.